跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AG-TADALAFIL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AG-TADALAFIL
Authorized
STANDARD
AG-TADALAFIL
angita pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ed415bd240f693a0
Company
angita pharma inc.
Type
Standard
Approval Details
Approval Id
ed415bd240f693a0
Drug Approval Canada Name
AG-TADALAFIL
Product Name
AG-TADALAFIL
Status
Marketed
Status Date
2022-03-16
Original Market Date
2022-03-16
Din
02481405
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:12.12
Atc Original
G04BE08 TADALAFIL
Atc Name
g 04 be 08
Aig Number
0149485004
Company Name
angita pharma inc.
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Active Ingredients
TADALAFIL
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ed415bd240f693a0
Type
Standard
Back to Health Canada Approvals